Biogen (BIIB)
NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-07-08
$200.36-2.60%
Close 2026-07-08 · 1-day change
Reading BIIB? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BIIB free→NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-07-08
Reading BIIB? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BIIB free→QuarterlyIQ Insights · BIIB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | — | 9,890.6 | 9,675.9 | 9,835.6 | 10,173.4 | 10,981.7 | 13,444.6 | 14,377.9 | 11,448.8 | 11,448.8 | 11,448.8 | 10,763.8 | 5,516.5 | 5,516.5 | 5,516.5 | 5,048.6 | 4,097.5 | 4,097.5 |
| Total Revenues | — | 9,890.6 | 9,675.9 | 9,835.6 | 10,173.4 | 10,981.7 | 13,444.6 | 14,377.9 | 11,448.8 | 11,448.8 | 11,448.8 | 10,763.8 | 5,516.5 | 5,516.5 | 5,516.5 | 5,048.6 | 4,097.5 | 4,097.5 |
| Cost of Revenues | — | 2,404.2 | 2,310.4 | 2,533.4 | 2,278.3 | 2,109.7 | 1,805.2 | 1,955.4 | 1,478.7 | — | — | — | — | — | 545.5 | 466.8 | 402.0 | 402.0 |
| Gross Profit | — | — | — | — | — | — | 11,639.4 | 12,422.5 | 11,636.6 | 9,970.1 | 9,970.1 | 9,523.4 | 8,532.3 | 4,971.0 | 4,971.0 | 4,581.9 | 4,316.2 | — |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | — | 2,433.6 | 2,403.7 | 2,549.7 | 2,403.6 | 2,674.3 | 2,504.5 | 2,374.7 | 1,946.6 | 1,947.9 | 1,947.9 | 2,113.1 | 1,277.5 | 1,277.5 | 1,277.5 | 1,056.1 | 925.3 | 925.3 |
| R&D Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,334.9 | 1,219.6 | 1,072.1 | 1,072.1 |
| Operating Income | — | 1,556.5 | 1,906.0 | 1,296.8 | 3,591.8 | 2,840.7 | 4,550.1 | 7,042.6 | 5,151.7 | 5,150.4 | 5,150.4 | 4,891.0 | 1,855.8 | 1,855.8 | 1,855.8 | 1,724.7 | 1,213.6 | 1,213.6 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | — | 267.5 | 250.3 | 246.9 | 246.6 | 253.6 | 222.5 | 187.4 | 260.0 | 260.0 | 260.0 | 95.5 | 36.5 | 36.5 | 36.5 | 33.0 | 52.0 | — |
| Interest & Investment Income | — | 125.0 | 67.6 | 276.5 | 89.3 | 11.0 | 42.0 | 120.0 | 63.4 | 63.4 | 63.4 | 22.1 | 29.5 | 29.5 | 29.5 | 19.2 | 72.1 | — |
| Net Interest Expenses | — | 142.5 | 182.7 | (29.6) | 157.3 | 242.6 | 180.5 | 67.4 | 196.6 | 196.6 | 196.6 | 73.4 | 7.0 | 7.0 | 7.0 | 13.8 | (20.1) | — |
| Other Non-Operating Income / Expenses | — | (305.6) | (343.6) | (315.5) | 108.2 | (1,095.5) | 497.4 | 83.3 | (218.7) | (217.4) | — | — | — | — | — | — | — | — |
| Asset Writedown | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | 1,556.5 | 1,906.0 | 1,296.8 | 3,591.8 | 1,745.2 | 5,047.5 | 7,125.9 | 4,933.0 | 4,933.0 | 4,933.0 | 4,767.3 | 1,855.1 | 1,855.1 | 1,855.1 | 1,711.2 | 1,155.9 | 1,155.9 |
| Income Tax Expense | — | 263.6 | 273.8 | 135.3 | 632.8 | 52.5 | 992.3 | 1,158.0 | 1,237.3 | 1,237.3 | 1,237.3 | 1,161.6 | 470.6 | 470.6 | 470.6 | 444.5 | 365.8 | 365.8 |
| Net Income | ||||||||||||||||||
| Minority Interest | — | 0.0 | 0.0 | 0.4 | (85.3) | 171.5 | 59.9 | 0.0 | (7.1) | (7.1) | (7.1) | 46.2 | 0.0 | 0.0 | 0.0 | 32.3 | 6.9 | 6.9 |
| Net Income | 737.2 | 1,293.0 | 1,632.0 | 1,161.0 | 3,047.0 | 1,556.0 | 4,000.6 | 5,888.5 | 3,702.8 | 3,702.8 | 3,702.8 | 3,547.0 | 1,380.0 | 1,380.0 | 1,380.0 | 1,234.4 | 783.2 | 783.2 |
| Per Share | ||||||||||||||||||
| Basic EPS | — | 8.83 | 11.21 | 8.02 | 20.96 | 10.44 | 24.86 | 31.47 | 16.96 | 16.96 | 16.96 | 15.38 | 5.80 | 5.80 | 5.80 | 5.09 | 2.67 | 2.67 |
| Diluted EPS | — | 8.79 | 11.18 | 7.97 | 20.87 | 10.40 | 24.80 | 31.42 | 16.93 | 16.93 | 16.93 | 15.34 | 5.76 | 5.76 | 5.76 | 5.04 | 2.65 | 2.65 |
| Basic Weighted Avg Shares | — | 146.5 | 145.6 | 144.7 | 145.3 | 149.1 | 160.9 | 187.1 | 218.4 | 218.4 | 218.4 | 230.7 | 237.9 | 237.9 | 237.9 | 242.4 | 292.3 | 292.3 |
| Diluted Weighted Avg Shares | — | 147.1 | 145.9 | 145.6 | 146.0 | 149.6 | 161.3 | 187.4 | 218.8 | 218.8 | 218.8 | 231.2 | 239.7 | 239.7 | 239.7 | 245.0 | 295.0 | 295.0 |
| Supplemental | ||||||||||||||||||
| EBITDA | — | 2,336.4 | 2,579.2 | 1,791.6 | 4,110.2 | 3,328.4 | 5,007.3 | 7,723.2 | 5,834.4 | 5,833.1 | 5,833.1 | 5,491.4 | 2,221.5 | 2,221.5 | 2,221.5 | 2,083.6 | 1,675.7 | 1,675.7 |
| EBIT | — | 1,556.5 | 1,906.0 | 1,296.8 | 3,591.8 | 2,840.7 | 4,550.1 | 7,042.6 | 5,151.7 | 5,150.4 | 5,150.4 | 4,891.0 | 1,855.8 | 1,855.8 | 1,855.8 | 1,724.7 | 1,213.6 | 1,213.6 |
| Effective Tax Rate | — | 16.9% | 14.4% | 10.4% | 17.6% | 3.0% | 19.7% | 16.3% | 25.1% | 25.1% | 25.1% | 24.4% | 25.4% | 25.4% | 25.4% | 26.0% | 31.6% | 31.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.